Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics

被引:10
|
作者
Lin, Zhi [1 ]
Cheng, Xi [1 ]
Zheng, Hui [1 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Chengdu 610072, Peoples R China
关键词
Coumarin; Umbelliferone; Pharmacology; Anti-oxidant; Anti-inflammatory; IN-VITRO EVALUATION; OXIDATIVE STRESS; ALPHA-GLUCOSIDASE; ANTIINFLAMMATORY ACTIVITIES; ANTIMICROBIAL ACTIVITIES; INDUCED HEPATOTOXICITY; CHEMICAL-CONSTITUENTS; ISCHEMIA-REPERFUSION; COUMARIN DERIVATIVES; ATOPIC-DERMATITIS;
D O I
10.1007/s10787-023-01256-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coumarin, a plant secondary metabolite, has various pharmacological activities, including antioxidant stress and anti-inflammatory effects. Umbelliferone, a common coumarin compound found in almost all higher plants, has been extensively studied for its pharmacological effects in different disease models and doses with complex action mechanisms. This review aims to summarize these studies and provide useful information to relevant scholars. The pharmacological studies demonstrate that umbelliferone has diverse effects such as anti-diabetes, anti-cancer, anti-infection, anti-rheumatoid arthritis, neuroprotection, and improvement of liver, kidney, and myocardial tissue damage. The action mechanisms of umbelliferone include inhibition of oxidative stress, inflammation, and apoptosis, improvement of insulin resistance, myocardial hypertrophy, and tissue fibrosis, in addition to regulation of blood glucose and lipid metabolism. Among the action mechanisms, the inhibition of oxidative stress and inflammation is the most critical. In short, these pharmacological studies disclose that umbelliferone is expected to treat many diseases, and more research should be conducted.
引用
收藏
页码:1731 / 1750
页数:20
相关论文
共 50 条
  • [1] Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics
    Zhi Lin
    Xi Cheng
    Hui Zheng
    Inflammopharmacology, 2023, 31 : 1731 - 1750
  • [2] Chrysophanol: a review of its pharmacology, toxicity and pharmacokinetics
    Xie, Long
    Tang, Hailong
    Song, Jiawen
    Long, Jiaying
    Zhang, Linlin
    Li, Xiaofang
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (10) : 1475 - 1487
  • [3] Palmatine: A review of its pharmacology, toxicity and pharmacokinetics
    Long, Jiaying
    Song, Jiawen
    Zhong, Li
    Liao, Yanmei
    Liu, Luona
    Li, Xiaofang
    BIOCHIMIE, 2019, 162 : 176 - 184
  • [4] Bergapten: A review of its pharmacology, pharmacokinetics, and toxicity
    Liang, Youdan
    Xie, Long
    Liu, Kai
    Cao, Yi
    Dai, Xiaolin
    Wang, Xian
    Lu, Jing
    Zhang, Xumin
    Li, Xiaofang
    PHYTOTHERAPY RESEARCH, 2021, 35 (11) : 6131 - 6147
  • [5] Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
    Dong, Xiaoxv
    Fu, Jing
    Yin, Xingbin
    Cao, Sali
    Li, Xuechun
    Lin, Longfei
    Huyiligeqi
    Ni, Jian
    PHYTOTHERAPY RESEARCH, 2016, 30 (08) : 1207 - 1218
  • [6] Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
    Li, Xiang
    Zhang, Chuan-Tao
    Ma, Wei
    Xie, Xin
    Huang, Qun
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] Magnoflorine: A review of its pharmacology, pharmacokinetics and toxicity
    Xu, Tong
    Kuang, Tingting
    Du, Huan
    Li, Qi
    Feng, Tu
    Zhang, Yi
    Fan, Gang
    PHARMACOLOGICAL RESEARCH, 2020, 152
  • [8] Limonin: A Review of Its Pharmacology, Toxicity, and Pharmacokinetics
    Fan, Shunming
    Zhang, Chunling
    Luo, Ting
    Wang, Jiaqi
    Tang, Yu
    Chen, Zhimin
    Yu, Lingying
    MOLECULES, 2019, 24 (20):
  • [9] Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity
    Gao, Xiao-Yan
    Li, Xu-Yang
    Zhang, Cong-Ying
    Bai, Chun-Ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Sophoridine: A review of its pharmacology, pharmacokinetics and toxicity
    Wang, Qi
    Li, Ying
    Li, Kun-Wei
    Zhou, Chang-Zheng
    PHYTOMEDICINE, 2022, 95